Consolidated Financial Results for the Nine Months Ended March 31, 2026 (Under Japanese GAAP)5/15 15:30TDnetPDF(395KB)
Notice Regarding Conclusion of an Exclusive Distribution Agreement for Embolization Agents in the Japanese Market4/9 15:30TDnetPDF(183KB)
Notice Regarding Revision of Forecast for Dividends due to the Payment of a 50th Anniversary Commemorative Dividend and an Increase in Ordinary Divide2/13 15:30TDnetPDF(117KB)
Notice Regarding Revision of Full-Year Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 2026[Supplementary Materials]2/13 15:30TDnetPDF(1MB)
Notice Regarding Revision (Upward Revision) of Full-Year Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 20262/13 15:30TDnetPDF(126KB)
Consolidated Financial Results for the Six Months Ended December 31, 2025 (Under Japanese GAAP)2/13 15:30TDnetPDF(411KB)
Consolidated Financial Results for the Three Months Ended September 30, 2025 (Under Japanese GAAP)2025/11/14TDnetPDF(387KB)
Notice Concerning the Status and Completion of Acquisition of Treasury Shares2025/10/31TDnetPDF(90KB)